Update on the Treatment of Salivary Gland Carcinomas.

Acinic cell carcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma Salivary gland carcinoma Salivary gland malignancy

Journal

Surgical oncology clinics of North America
ISSN: 1558-5042
Titre abrégé: Surg Oncol Clin N Am
Pays: United States
ID NLM: 9211789

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 8 9 2024
pubmed: 8 9 2024
entrez: 7 9 2024
Statut: ppublish

Résumé

Salivary gland carcinoma is a rare form of head and neck carcinoma, but it comprises a variety of subsites and histologic subtypes that each present with unique clinical courses and management challenges. Preoperative work-up generally consists of fine-needle aspiration cytology and MRI. However, because of the large variety of subtypes, there are often challenges obtaining a histologic diagnosis before surgery. Upfront surgery at the primary site leads to the greatest improvement in survival. Posttreatment surveillance of these patients is important. This article discusses some of the current controversies in the management of salivary gland carcinomas.

Identifiants

pubmed: 39244292
pii: S1055-3207(24)00033-4
doi: 10.1016/j.soc.2024.04.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-760

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have nothing to disclose.

Auteurs

Danielle M Gillard (DM)

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, CA, USA.

Zainab Farzal (Z)

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, CA, USA; Department of Otolaryngology Head and Neck Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9035, USA.

William R Ryan (WR)

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, CA, USA. Electronic address: William.ryan@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH